Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interventional Management of Stroke (IMS) Study.

Trial Profile

Interventional Management of Stroke (IMS) Study.

Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Alteplase (Primary) ; Alteplase (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms IMS
  • Most Recent Events

    • 18 Jul 2012 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Additional lead trial centre (National Institute of Neurological Disorders and Stroke) and lead trial investigators (Broderick JP, Tomsick TA) added as reported by ClinicalTrials.gov
    • 04 Jun 2007 Status changed from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top